The U.S. Food and Drug Administration (FDA) has accepted Gradient Denervation Technologies, a company that makes an ultrasound-based catheter to treat pulmonary hypertension (PH), into a program to facilitate development of medical devices. Acceptance into the FDA’s Total Product Life Cycle Advisory Program (TAP) pilot will give…

You may have noticed that I haven’t been writing much in the past few months. That’s because I recently suffered a fall at home that was unrelated to my pulmonary hypertension (PH). Rather, it happened because of my clumsiness as I tried to tackle my to-do list. The fall…